115 related articles for article (PubMed ID: 32924331)
21. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
23. Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.
Pappone C; Vicedomini G; Augello G; Mazzone P; Nardi S; Rosanio S
Am J Cardiol; 2003 May; 91(9A):74F-80F. PubMed ID: 12729853
[TBL] [Abstract][Full Text] [Related]
24. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
[TBL] [Abstract][Full Text] [Related]
25. Comparison of pharmacological treatment alone vs. treatment combined with implantable cardioverter defibrillator therapy in patients older than 75 years.
Cortés M; Palfy JA; Lopez M; Martínez J; Rivero AL; Devesa A; Franco-Peláez JA; Briongos S; Taibo-Urquia M; Benezet J; Rubio JM
ESC Heart Fail; 2018 Oct; 5(5):884-891. PubMed ID: 29936703
[TBL] [Abstract][Full Text] [Related]
26. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
27. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
[TBL] [Abstract][Full Text] [Related]
28. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
Naser N
Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
[TBL] [Abstract][Full Text] [Related]
29. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction.
Chatterjee NA; Moorthy MV; Pester J; Schaecter A; Panicker GK; Narula D; Lee DC; Goldberger JJ; Kadish A; Cook NR; Albert CM;
JAMA Cardiol; 2018 Jul; 3(7):591-600. PubMed ID: 29801082
[TBL] [Abstract][Full Text] [Related]
30. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
31. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial.
Vaduganathan M; Claggett BL; Chatterjee NA; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Hegde SM; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):653-661. PubMed ID: 29501806
[TBL] [Abstract][Full Text] [Related]
32. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics of heart failure with recovered ejection fraction].
Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
[No Abstract] [Full Text] [Related]
34. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.
van Deursen VM; Urso R; Laroche C; Damman K; Dahlström U; Tavazzi L; Maggioni AP; Voors AA
Eur J Heart Fail; 2014 Jan; 16(1):103-11. PubMed ID: 24453099
[TBL] [Abstract][Full Text] [Related]
35. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
[TBL] [Abstract][Full Text] [Related]
36. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
Veltmann C; Winter S; Duncker D; Jungbauer CG; Wäßnig NK; Geller JC; Erath JW; Goeing O; Perings C; Ulbrich M; Roser M; Husser D; Gansera LS; Soezener K; Malur FM; Block M; Fetsch T; Kutyifa V; Klein HU
Clin Res Cardiol; 2021 Jan; 110(1):102-113. PubMed ID: 32377784
[TBL] [Abstract][Full Text] [Related]
37. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
38. [A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure receiving resynchronization therapy].
Qi SY; Wang DM; Yu HB; Ding C; Tian FL; Ru LS; Li J; Zhang B; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):951-955. PubMed ID: 27903393
[No Abstract] [Full Text] [Related]
39. Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction.
Walker AMN; Drozd M; Hall M; Patel PA; Paton M; Lowry J; Gierula J; Byrom R; Kearney L; Sapsford RJ; Witte KK; Kearney MT; Cubbon RM
J Am Heart Assoc; 2018 Oct; 7(20):e009684. PubMed ID: 30371261
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
